VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
46 hedge funds and large institutions have $7.06M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 24 reducing their positions, and 50 closing their positions.
Holders
46
Holders Change
-49
Holders Change %
-51.58%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
11
Reduced
24
Closed
50
Calls
$536K
Puts
$6K
Net Calls
+$530K
Net Calls Change
+$457K
Top Buyers
1 |
1
Millennium Management
New York
|
$293K |
2 |
2
Morgan Stanley
New York
|
$257K |
3 |
YIH
3
Y-Intercept (HK)
Hong Kong
|
$131K |
4 |
4
Jane Street
New York
|
$40.1K |
5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$41.9K |
Top Sellers
1 |
PA
1
Perceptive Advisors
New York
|
$4.54M |
2 |
2
BlackRock
New York
|
$369K |
3 |
3
State Street
Boston,
Massachusetts
|
$98.9K |
4 |
4
Renaissance Technologies
New York
|
$0 |
5 |
5
Bank of New York Mellon
New York
|
$0 |